tiprankstipranks
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
US Market
Holding KYTX?
Track your performance easily

Kyverna Therapeutics, Inc. (KYTX) Financial Statements

642 Followers

Kyverna Therapeutics, Inc. Financial Overview

Kyverna Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-3.069; its P/E ratio is -1.30; Kyverna Therapeutics, Inc. is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -34.46M$ -28.76M---
EBITDA$ -33.90M$ -27.95M---
Net Income Common Stockholders$ -34.49M$ -28.80M$ -20.67M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 321.59M$ 346.24M$ 57.54M$ 77.27M$ 51.32M
Total Assets$ 339.20M$ 363.12M$ 75.19M$ 92.49M$ 66.92M
Total Debt$ 9.14M$ 10.00M$ 9.08M$ 9.64M$ 10.56M
Net Debt$ -312.45M$ -336.24M$ -48.46M$ -67.63M$ -40.76M
Total Liabilities$ 36.49M$ 29.61M$ 26.02M$ 23.72M$ 20.25M
Stockholders Equity$ 302.71M$ 333.51M$ -131.40M$ 68.77M$ -74.00M
Cash Flow-
Free Cash Flow$ -27.59M$ -25.20M$ -18.90M--
Operating Cash Flow$ -27.49M$ -24.18M$ -18.56M--
Investing Cash Flow$ 676.00K$ -67.92M$ 31.68M--
Financing Cash Flow$ -152.00K$ -569.00K$ -1.43M--
Currency in USD

Kyverna Therapeutics, Inc. Earnings and Revenue History

Kyverna Therapeutics, Inc. Debt to Assets

Kyverna Therapeutics, Inc. Cash Flow

Kyverna Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis